ENTX
Entera Bio Ltd
2.70$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | -26.3% | +95.2% | -48.8% | -100.0% | – | – | – | – | – | |
| – | -7.1% | +0.0% | +269.2% | -12.5% | +95.2% | -48.8% | -83.3% | +14.3% | -12.5% | +0.0% | -100.0% | – | |
| – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | -27.2% | -26.8% | +50.4% | +36.0% | -18.7% | -6.5% | +35.4% | +7.6% | +5.1% | +30.6% | +42.6% | – | |
| – | -5.4% | +36.4% | -18.0% | +41.9% | -26.4% | +26.8% | -20.3% | +40.5% | -17.9% | -2.7% | +5.7% | – | |
| – | -17.8% | +4.5% | +6.1% | +39.0% | -22.6% | +9.7% | +4.1% | +21.7% | -6.3% | +16.1% | +29.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7,089.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.